Macrolide Drugs Market by Drug Type, 16-membered ring agents, and Ketolides, By Distribution Channels: Global Industry Perspective, Comprehensive Analysis and Forecast, 2018

The report covers forecast and analysis for the macrolide drugs market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the macrolide drugs market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the macrolide drugs market on a global level.

In order to give the users of this report a comprehensive view of the macrolide drugs market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein types, sales channel, and regional segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new type launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the market on the global and regional basis.

The study provides a decisive view of the macrolide drugs market by segmenting the market based on types, sales channel, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. Based on type, macrolide drugs market has been segmented into 14-membered ring agents, 14-membered ring agents, 15-membered ring agents (Azalides), 16-membered ring agents, and Ketolides. Based on the sales channel, the macrolide drugs market has been segmented into hospital pharmacies, clinics, hospitals, retail pharmacies, and online pharmacies. Based on region, macrolide drugs market is further segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further bifurcation into major countries including the U.S. Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for macrolide drugs market based on individual segment and sales channel in all the regions and countries.

The report also includes detailed profiles of end players such as Abbott Laboratories, Akorn, Inc., Eli Lilly & Co., Fresenius Kabi USA, Gland Pharma Limited, Neo Química, Macrolide Pharmaceuticals, Mylan N.V., Pfizer, Inc., Sanofi, Merck & Co., Sandoz International GmbH, Teva Pharmaceutical Industries Ltd., and WOCKHARDT.

This report segments the global macrolide drugs market as follows:

Global Macrolide Drugs Market: By Type

14-membered ring agents
15-membered ring agents (Azalides)
16-membered ring agents
Ketolides

Global Macrolide Drugs Market: By Sales Channel

Hospital pharmacies
Clinics
Hospitals
Retail pharmacies
Online pharmacies

Global Macrolide Drugs market: By Region

North America
The U.S.

Europe
UK
France
Germany

Asia Pacific
China
Japan
India

Latin America
Brazil

Middle East and Africa

Chapter 1. Introduction
- 1.1. Report description and scope
- 1.2. Research scope
- 1.3. Research methodology
  - 1.3.1. Market research process
  - 1.3.2. Market research methodology
Chapter 2. Executive Summary
- 2.1. Global Macrolide Drugs market, 2015 - 2024 (USD Billion)
- 2.2. Global Macrolide Drugs market : Snapshot
Chapter 3. Macrolide Drugs market- Market Dynamics
- 3.1. Introduction
- 3.2. Market drivers
  - 3.2.1. Global Macrolide Drugs market drivers: Impact analysis
  - 3.2.2. Increasing incidences of cancer
  - 3.2.3. Increasing geriatric population
- 3.3. Market Restraints
  - 3.3.1. Global Macrolide Drugs market restraints: Impact analysis
  - 3.3.2. Lack of infrastructure
- 3.4. Opportunities
  - 3.4.1. Technological advancements in Macrolide Drugs market Types
- 3.5. Porter's five forces analysis
  - 3.5.1. Bargaining power of suppliers
  - 3.5.2. Bargaining power of buyers
  - 3.5.3. Threat from new entrants
  - 3.5.4. Threat from new substitutes
  - 3.5.5. Degree of competition
- 3.6. Market attractiveness analysis
  - 3.6.1. Market attractiveness analysis, by Type segment
  - 3.6.2. Market attractiveness analysis, by sales channel segment
  - 3.6.3. Market attractiveness analysis, by regional segment
Chapter 4. Global Macrolide Drugs market - Competitive Landscape
- 4.1. Company Market Share Analysis
  - 4.1.1. Global Macrolide Drugs market: company market share, 2015
- 4.2. Strategic Development
  - 4.2.1. Acquisitions & Mergers
  - 4.2.2. New Type Launch
  - 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
  - 4.2.4. Research and Development, Regional Expansion
Chapter 5. Global Macrolide Drugs market - Type Segment Analysis
- 5.1. Global Macrolide Drugs market: Type overview
  - 5.1.1. Global Macrolide Drugs market revenue share, by Type, 2015 and 2024
- 5.2. 14-membered ring agents
  - 5.2.1. Global 14-membered ring agents market, 2015 - 2024(USD Billion)
- 5.3. 15-membered ring agents (Azalides)
  - 5.3.1. Global 15-membered ring agents (Azalides) market, 2015 - 2024(USD Billion)
- 5.4. 16-membered ring agents
  - 5.4.1. Global 16-membered ring agents market, 2015 - 2024(USD Billion)
- 5.5. Ketolides
  - 5.5.1. Global Ketolides market, 2015 - 2024(USD Billion)
Chapter 6. Global Macrolide Drugs market -Sales Channel Segment Analysis
- 6.1. Global Macrolide Drugs market: Sales Channel overview
  - 6.1.1. Global Macrolide Drugs market revenue share, by sales channel, 2015 and 2022
- 6.2. Hospital pharmacies
  - 6.2.1. Global Hospital pharmacies market, 2015 - 2024(USD Billion)
- 6.3. Clinics
  - 6.3.1. Global Clinics market, 2015 - 2024(USD Billion)
- 6.4. Hospitals
  - 6.4.1. Global Hospitals market, 2015 - 2024(USD Billion)
- 6.5. Retail pharmacies
  - 6.5.1. Global Retail pharmacies market, 2015 - 2024(USD Billion)
- 6.6. Online pharmacies
  - 6.6.1. Global Online pharmacies market, 2015 - 2024(USD Billion)
Chapter 7. Global Macrolide Drugs market - Regional Segment Analysis
- 7.1. Global Macrolide Drugs market: Regional overview
  - 7.1.1. Global Macrolide Drugs market revenue share, by region, 2015 and 2021
- 7.2. North America
  - 7.2.1. North America Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
  - 7.2.2. North America Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
  - 7.2.3. U.S.
    - 7.2.3.1. U.S. Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
    - 7.2.3.2. U.S. Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
  - 7.2.4. Canada
    - 7.2.4.1. Canada Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
    - 7.2.4.2. Canada Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
  - 7.2.5. Rest of North America
    - 7.2.5.1. Rest of North America Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
    - 7.2.5.2. Rest of North America Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
- 7.3. Europe
  - 7.3.1. Europe Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
  - 7.3.2. Europe Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
  - 7.3.3. Germany
    - 7.3.3.1. Germany Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
    - 7.3.3.2. Germany Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
  - 7.3.4. U.K.
    - 7.3.4.1. U.K. Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
    - 7.3.4.2. U.K. Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
  - 7.3.5. France
    - 7.3.5.1. France Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
    - 7.3.5.2. France Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
  - 7.3.6. Italy
    - 7.3.6.1. Italy Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
    - 7.3.6.2. Italy Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
  - 7.3.7. Spain
    - 7.3.7.1. Spain Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
    - 7.3.7.2. Spain Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
  - 7.3.8. Russia
    - 7.3.8.1. Russia Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
    - 7.3.8.2. Russia Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
  - 7.3.9. Rest of Europe
    - 7.3.9.1. Rest of Europe Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
    - 7.3.9.2. Rest of Europe Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
- 7.4. Asia Pacific
  - 7.4.1. Asia Pacific Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
  - 7.4.2. Asia Pacific Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
  - 7.4.3. China
    - 7.4.3.1. China Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
    - 7.4.3.2. China Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
  - 7.4.4. Japan
    - 7.4.4.1. Japan Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
    - 7.4.4.2. Japan Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
  - 7.4.5. India
    - 7.4.5.1. India Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
    - 7.4.5.2. India Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
  - 7.4.6. Australia
    - 7.4.6.1. Australia Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
    - 7.4.6.2. Australia Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
- 7.5. Latin America
  - 7.5.1. Latin America Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
  - 7.5.2. Latin America Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
  - 7.5.3. Mexico
    - 7.5.3.1. Mexico Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
    - 7.5.3.2. Mexico Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
  - 7.5.4. Brazil
    - 7.5.4.1. Brazil Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
    - 7.5.4.2. Brazil Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
  - 7.5.5. Argentina
    - 7.5.5.1. Argentina Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
    - 7.5.5.2. Argentina Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
  - 7.5.6. Rest of Latin America
    - 7.5.6.1. Rest of Latin America Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
    - 7.5.6.2. Rest of Latin America Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
- 7.6. Middle East and Africa
  - 7.6.1. Middle East and Africa Macrolide Drugs market revenue, by Type, 2015 - 2024(USD Billion)
  - 7.6.2. Middle East and Africa Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
  - 7.6.3. Saudi Arabia
    - 7.6.3.1. Saudi Arabia Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
    - 7.6.3.2. Saudi Arabia Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
  - 7.6.4. UAE
    - 7.6.4.1. UAE Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
    - 7.6.4.2. UAE Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
  - 7.6.5. Qatar
    - 7.6.5.1. Qatar Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
    - 7.6.5.2. Qatar Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
  - 7.6.6. South Africa
    - 7.6.6.1. South Africa Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
    - 7.6.6.2. South Africa Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
  - 7.6.7. Rest of Middle East & Africa
    - 7.6.7.1. Middle East & Africa Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
    - 7.6.7.2. Middle East & Africa Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
Chapter 8. Company Profile
- 8.1. Abbott Laboratories
  - 8.1.1. Overview
  - 8.1.2. Financials
  - 8.1.3. Therapy portfolio
  - 8.1.4. Business strategy
  - 8.1.5. Recent developments
- 8.2. Akorn, Inc.
  - 8.2.1. Overview
  - 8.2.2. Financials
  - 8.2.3. Therapy portfolio
  - 8.2.4. Business strategy
  - 8.2.5. Recent developments
- 8.3. Eli Lilly & Co.
  - 8.3.1. Overview
  - 8.3.2. Financials
  - 8.3.3. Therapy portfolio
  - 8.3.4. Business strategy
  - 8.3.5. Recent developments
- 8.4. Fresenius Kabi USA
  - 8.4.1. Overview
  - 8.4.2. Financials
  - 8.4.3. Therapy portfolio
  - 8.4.4. Business strategy
  - 8.4.5. Recent developments
- 8.5. Gland Pharma Limited
  - 8.5.1. Overview
  - 8.5.2. Financials
  - 8.5.3. Therapy portfolio
  - 8.5.4. Business strategy
  - 8.5.5. Recent developments
- 8.6. Macrolide Pharmaceuticals
  - 8.6.1. Overview
  - 8.6.2. Financials
  - 8.6.3. Therapy portfolio
  - 8.6.4. Business strategy
  - 8.6.5. Recent developments
- 8.7. Neo Química
  - 8.7.1. Overview
  - 8.7.2. Financials
  - 8.7.3. Therapy portfolio
  - 8.7.4. Business strategy
  - 8.7.5. Recent developments
- 8.8. Mylan N.V.
  - 8.8.1. Overview
  - 8.8.2. Financials
  - 8.8.3. Therapy portfolio
  - 8.8.4. Business strategy
  - 8.8.5. Recent developments
- 8.9. Pfizer, Inc.
  - 8.9.1. Overview
  - 8.9.2. Financials
  - 8.9.3. Therapy portfolio
  - 8.9.4. Business strategy
  - 8.9.5. Recent developments
- 8.10. Merck & Co.
  - 8.10.1. Overview
  - 8.10.2. Financials
  - 8.10.3. Therapy portfolio
  - 8.10.4. Business strategy
  - 8.10.5. Recent developments
- 8.11. Merck & Co.
  - 8.11.1. Overview
  - 8.11.2. Financials
  - 8.11.3. Therapy portfolio
  - 8.11.4. Business strategy
  - 8.11.5. Recent developments
- 8.12. Sandoz International GmbH
  - 8.12.1. Overview
  - 8.12.2. Financials
  - 8.12.3. Therapy portfolio
  - 8.12.4. Business strategy
  - 8.12.5. Recent developments
- 8.13. Teva Pharmaceutical Industries Ltd.
  - 8.13.1. Overview
  - 8.13.2. Financials
  - 8.13.3. Therapy portfolio
  - 8.13.4. Business strategy
  - 8.13.5. Recent developments
- 8.14. WOCKHARDT
  - 8.14.1. Overview
  - 8.14.2. Financials
  - 8.14.3. Therapy portfolio
  - 8.14.4. Business strategy
  - 8.14.5. Recent developments